Global NASH Biomarker Market By End User: Adoption Trends in Hospitals, Diagnostic Laboratories, and Research Institutio
The global NASH (Non-Alcoholic Steatohepatitis) biomarker market by end user is expanding due to rising prevalence of liver-related metabolic disorders and increasing adoption of advanced diagnostic solutions.
Key end users include hospitals, diagnostic laboratories, and research institutions. Hospitals remain the primary adopters of biomarker technologies, driven by patient demand for accurate and early diagnosis. Diagnostic laboratories are leveraging high-throughput blood-based, imaging, and molecular biomarker testing to improve patient monitoring and support clinical decision-making. Research institutions play a critical role in validating new biomarkers, developing innovative assays, and supporting clinical trials.
37 vues